COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04NVG
|
|||
Drug Name |
Angiotensin (1-7)
|
|||
Synonyms |
Angiotensin (1-7); angiotensin 1-7; 51833-78-4; Angiotensin i (1-7); Angiotensin II (1-7) heptapeptide; angiotensin-(1-7); angiotensin II (1-7); TXA127; 8-Des-phe-angiotensin II; UNII-IJ3FUK8MOF; ASP-ARG-VAL-TYR-ILE-HIS-PRO; IJ3FUK8MOF; Angiotensin, Canine, Rat; Angiotensin I/II (1-7); Ang-(1-7); CHEBI:55438; TXA-127; Ile(5)-angiotensin II (1-7); 39386-80-6; Angiotensin II, 5-L-isoleucine-8-de-L-phenylalanine-; Human angiotensin-(1-7); 1-7-Human angio; Angiotensin (1-7)
|
|||
Drug Type |
Protein/peptide drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 2/3 | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL
|
|||
Canonical SMILES |
CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N
|
|||
CAS Number |
CAS 39386-80-6
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04332666) Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.